An investigation on behalf of investors of Axcella Health Inc. (NASDAQ: AXLA) shares over potential securities laws violations by Axcella Health Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Axcella Health Inc. (NASDAQ: AXLA) concerning whether a series of statements by Axcella Health Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Cambirdge, MA based Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. Axcella Health Inc. went public in May 2019 and sold over 3.5 million shares at $20 per share in the initial public offering (IPO). Since then, shares of Axcella Health Inc. (NASDAQ: AXLA) declined to as low as $4.99 per share on October 7, 2019.